Intrauterine Devices Market

Intrauterine Devices Market Size

Intrauterine Devices Market size was valued at around USD 4.3 billion in 2023 and is expected to reach over USD 10.1 billion by 2032 at a CAGR of 10.3% from 2024 to 2032. The significantly high number of unintended pregnancies, favorable government initiatives and growing awareness are among the key factors driving the growth of the market.

Several factors contribute to these unintended pregnancies including social, economic, educational, and healthcare system issue. As per the United Nations Population Fund, nearly half of all pregnancies, totaling 121 million each year throughout the world, are unintended. IUDs are one of the most effective forms of reversible contraception available. They have a very low failure rate, with less than 1% chance of pregnancy per year of use for both hormonal and copper IUDs. This reliability makes them highly attractive to individuals seeking reliable birth control to avoid unintended pregnancies. These factors underscore the complex interplay of social, economic, educational, and healthcare system issues that contribute to the high rates of unintended pregnancies, and ultimately increases the intrauterine devices demand in the market.

Intrauterine devices (IUDs) are small, T-shaped contraceptive devices inserted into the uterus to prevent pregnancy. These devices are made of flexible plastic and are designed to be a long-term, reversible form of birth control.

Intrauterine Devices Market Trends

Recent technological advancements in the design and insertion techniques of intrauterine devices (IUDs) have significantly contributed to the growth of the IUD market. These innovations aim to enhance the safety, effectiveness, and ease of use of IUDs, making them a more attractive option for contraception.

• Improvements in IUD design and materials have significantly reduced discomfort and side effects, making IUDs more acceptable to a wider range of women.
  
• Additionally, the development of more advanced insertion kits that are easier to use has improved the safety and efficiency of the insertion process. These kits often include pre-loaded IUDs and ergonomic applicators.
  
• Moreover, the advances in hormone delivery and longer-lasting copper IUDs offer extended protection, providing a more reliable and convenient contraception method.
  
• Furthermore, research and development are ongoing for smart IUDs that can monitor and report data on hormone levels and uterine environment, providing personalized healthcare insights and timely interventions.
  
• These technological advancements and their resulting benefits play a crucial role in driving the growth of the IUD market by making them a more viable and appealing contraceptives for women worldwide.
  

Intrauterine Devices Market Analysis

Based on product, the intrauterine devices market is categorized into copper IUD and hormonal IUD. The hormonal IUD segment dominated the market with a revenue of around USD 2.3 billion in 2023.

• Hormonal IUDs release progestin which not only prevents pregnancy but also provides additional benefits such as reducing menstrual bleeding and cramps. This dual function makes them highly appealing to many women.
  
• Moreover, hormonal IUDs offer long-term protection ranging from 3 to 7 years, making them a convenient option for long-term contraception, and increased their demand in the market.
  

Based on age group segment, the intrauterine devices market is categorized into 15-19, 20-24, 25-29, 30-34, 35-39, 40-44, and 45+. The 30-34 age group segment held leading share in the market with a revenue of around USD 1.2 billion in 2023.

• Women in their mid-to-late twenties and thirties are often in stable relationships and may seek reliable contraception that is effective and easy to manage. Further, this age group also sees significant IUD adoption owing to increased awareness regarding healthy difference in age between two pregnancies.
  
• Moreover, healthcare providers often recommend IUDs to women in their 30s because they are highly effective and require less frequent medical intervention compared to other contraceptive methods.
  

Based on end-use, the intrauterine devices market is categorized into hospitals, gynecology clinics, and community health care centers. The hospital segment dominated the market with a revenue share of around 46.8% in 2023.

• Hospitals offer a broad spectrum of healthcare services under one roof, including gynecological care, family planning, and contraceptive services, making them a convenient choice for women seeking IUDs.
  
• Additionally, many health insurance plans are more likely to cover procedures performed in hospitals, making it financially easier for patients to access IUD services in these settings.
  

North America intrauterine devices market accounted for USD 1.5 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.

• Government and non-government organizations in the region have been conducting extensive awareness campaigns about the benefits and safety of IUDs. This has led to increased knowledge and acceptance among women.  
  
• Additionally, the high rate of unintended pregnancies in North America underscores the need for effective contraceptive methods. IUDs offer a reliable solution, leading to higher adoption rates.
  

The U.S. intrauterine devices market held majority market share and is anticipated to witness substantial growth, driven by numerous factors.

• Many health insurance plans in the U.S. cover the cost of IUDs, making them more accessible to a larger segment of the population.
  
• Furthermore, programs such as the Affordable Care Act (ACA) in the U.S. have mandated coverage for contraceptive methods, including IUDs, without additional out-of-pocket costs, contributing to their increased demand.
  

The intrauterine devices market in UK is expected to experience significant and promising growth from 2024 to 2032.

• Healthcare professionals in the UK often recommend IUDs for their effectiveness and convenience, influencing more women to choose this method.
  
• Additionally, the National Health Service (NHS) in the UK offers free IUDs as part of its contraceptive services. This makes IUDs accessible to a broad segment of the population, encouraging their use in the country.
  

Japan intrauterine devices market is anticipated to witness lucrative growth between 2024 – 2032.

• Many women in Japan are choosing to delay having children in favour of pursuing higher education and career opportunities, increasing the demand for long-term contraceptive methods.
  
• Furthermore, Japan's advanced healthcare infrastructure ensures that women have access to high-quality contraceptive services, including the latest IUD options.
  

Intrauterine Devices Market Share

The intrauterine devices industry is consolidated in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel devices with improved efficiency and cost-effectiveness are key market strategies for intrauterine device manufacturers, driving competition and innovation in the industry. This emphasis on innovation aims to address evolving clinical needs and enhance user outcomes, positioning companies to gain market share and meet the growing demand for advanced intrauterine devices.

Intrauterine Devices Market Companies

Some of the eminent market participants operating in the intrauterine devices industry include:

• Allergan (AbbVie Inc.)
• Bayer AG
• Contrel Europe
• CooperSurgical Inc.
• Durbin
• EUROGINE, S.L
• Gima S.p.A.
• HLL Lifecare Limited
• Meril Life Sciences Pvt. Ltd.
• Mona Lisa N.V.
• Mylan N.V. (Viatris)
• OCON Medical Ltd.
• Pregna International Ltd.
• Prosan International BV
• SMB Corporation of India
  

Intrauterine Devices Industry News:

• In November 2023, Bayer and CrossBay Medical Inc., announced the collaboration and option to license agreement that allow the development and production of a single-handed inserter to be combined with Bayer’s leading hormonal IUS portfolio. This strategy enhanced the company’s product portfolio and its competitiveness in the market.
  
• In December 2022, CooperSurgical, Inc., announced their partnership to launch a new consumer engagement solution for CooperSurgical's hormone-free IUD, Paragard, an FDA-approved intrauterine device that prevents pregnancy for up to 10 years. This launch enabled the company to have an increased customer base and better its sales prospects.
  

Intrauterine devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product   

• Copper IUD
• Hormonal IUD

Market, By Age Group  

• 15-19
• 20-24
• 25-29
• 30-34
• 35-39
• 40-44
• 45+

Market, By End-use 

• Hospitals
• Gynecology clinics
• Community health care centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa